Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The pathogenesis of Parkinson's disease
Huw R. Morris, Maria Grazia Spillantini, Carolyn M. Sue, et al.
The Lancet (2024) Vol. 403, Iss. 10423, pp. 293-304
Open Access | Times Cited: 267

Showing 1-25 of 267 citing articles:

The epidemiology of Parkinson's disease
Yoav Ben‐Shlomo, Sirwan K.L. Darweesh, Jorge J. Llibre‐Guerra, et al.
The Lancet (2024) Vol. 403, Iss. 10423, pp. 283-292
Closed Access | Times Cited: 286
The intricate brain–body interaction in psychiatric and neurological diseases
Francesco Di Gregorio, Simone Battaglia
Advances in Clinical and Experimental Medicine (2024) Vol. 33, Iss. 4, pp. 321-326
Open Access | Times Cited: 22
Recent advances in nanotechnology for Parkinson’s disease: diagnosis, treatment, and future perspectives
Virendra Kumar Yadav, Seshathiri Dhanasekaran, Nisha Choudhary, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 2
Neuronal FAM171A2 mediates α-synuclein fibril uptake and drives Parkinson’s disease
Kaimin Wu, Qianhui Xu, Yi-Qi Liu, et al.
Science (2025) Vol. 387, Iss. 6736, pp. 892-900
Closed Access | Times Cited: 2
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Xuxiang Zhang, Heng Wu, Beisha Tang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic
Shen‐Yang Lim, Ai Huey Tan, Azlina Ahmad, et al.
The Lancet Neurology (2024)
Closed Access | Times Cited: 8
Role of Oxidative Stress in Blood–Brain Barrier Disruption and Neurodegenerative Diseases
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1462-1462
Open Access | Times Cited: 8
Targeting uric acid: a promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases
Xu Lin, Chengwei Li, Tiantian Wan, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Integrating network pharmacology with molecular docking and dynamics to uncover therapeutic targets and signaling mechanisms of vitamin D3 in Parkinson’s disease
Cheng Wang, Yiling Wang, Qiu-Han Xu
Molecular Diversity (2025)
Closed Access | Times Cited: 1
MicroRNAs in Parkinson’s disease: From pathogenesis to diagnostics and therapeutic strategies
Dongying Zheng, Jibing Chween
Neuroscience (2025)
Closed Access | Times Cited: 1
The epidemiological risk and prevention and interventions in Parkinson's disease: from a nutrition-based perspective
Fan Zhang, Yuxian Liu, Yun Zhu, et al.
Journal of Nutrition (2025)
Closed Access | Times Cited: 1
Versatile Copper-Chalcogenide-Based Nanoparticles for the Treatment of Brain Diseases
Shuyang Xie, Hualong Liu, Ke Yang, et al.
Nano Biomedicine and Engineering (2025)
Open Access | Times Cited: 1
Intersecting molecular pathways in Synucleinopathies and Amyloidogenesis: Exploring shared mechanisms and therapeutic potential
Jashanpreet Kaur, Veerta Sharma, Heena Khan, et al.
Brain Research (2025), pp. 149568-149568
Closed Access | Times Cited: 1
Individual manifestations of Parkinson's disease after ten or more years of levodopa
H.L. Klawans
Movement Disorders (1986) Vol. 1, Iss. 3, pp. 187-192
Closed Access | Times Cited: 126
The vagus nerve: An old but new player in brain–body communication
Li Ma, Hanbing Wang, Kenji Hashimoto
Brain Behavior and Immunity (2024)
Open Access | Times Cited: 7
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model
Sandro Huenchuguala, Juan Segura‐Aguilar
Biomolecules (2024) Vol. 14, Iss. 6, pp. 673-673
Open Access | Times Cited: 6
Orchestration of antiviral responses within the infected central nervous system
Andreas Pavlou, Felix Mulenge, Olivia Luise Gern, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 9, pp. 943-958
Open Access | Times Cited: 6
Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications
Clara Mayer, Lluís Riera‐Ponsati, Sakari Kauppinen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
The role of iron transporters and regulators in Alzheimer’s disease and Parkinson’s disease: Pathophysiological insights and therapeutic prospects
Siqi Tian, Bing Wang, Yiqian Ding, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117419-117419
Open Access | Times Cited: 6
Enhancing Parkinson’s Disease Diagnosis through Stacking Ensemble-Based Machine Learning Approach
Riyadh M. Al-Tam, Fatma A. Hashim, Sarmad Maqsood, et al.
IEEE Access (2024) Vol. 12, pp. 79549-79567
Open Access | Times Cited: 5
Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders
Duraisamy Kempuraj, Kirk D. Dourvetakis, Jessica R. Cohen, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
The major histocompatibility complex participates in Parkinson’s disease
Rou Gu, Jianyu Pan, Maher Un Nisa Awan, et al.
Pharmacological Research (2024) Vol. 203, pp. 107168-107168
Open Access | Times Cited: 4
Tapping the Brakes on New Parkinson Disease Biological Staging
Njideka U. Okubadejo, Michael S. Okun, Joseph Jankovic
JAMA Neurology (2024) Vol. 81, Iss. 8, pp. 789-789
Closed Access | Times Cited: 4
Novel Aromatic Heterocycles for Dual MAO A and B Inhibitors: A Promising Strategy for Parkinson's Disease Treatment
Swati, Amir Raza, Bhupendra Singh, et al.
ChemistrySelect (2025) Vol. 10, Iss. 1
Closed Access
Linking evidence for targeted blood biomarkers in post-stroke cognitive impairment and dementia
Jie Hong, Katherine T Mun, Kyle C. Kern, et al.
Frontiers in Stroke (2025) Vol. 3
Open Access
Page 1 - Next Page

Scroll to top